Clinical trial
Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
NCT00132873 · Jazz Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00132873 |
|---|---|
| Title | Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy |
| Official title | Long-Term, Open-Label, Multi-Center Extension Trial of Xyrem® (Sodium Oxybate) Oral Solution for the Treatment of Narcolepsy |
| Lead sponsor | Jazz Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Narcolepsy |
| Intervention type | Drug |
| Interventions | Xyrem (sodium oxybate) oral solution |
| Enrollment | 59 |
| Start date | Oct 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 22, 2005 |
| Last update posted | Nov 25, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: